MAPT and Alzheimer disease: These 52 targets related to AD referred to cholinergic system dysfunction, glutamate/GABA system dysfunction, aggregates of amyloid-β peptide, hyper-phosphorylated tau, serotonergic system dysfunction, oxidative stress, neuroinflammation, mitochondrial dysfunction, and so on (Table 1).